Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone propionate in seasonal allergic rhinitis using Vienna Challenge Chamber and Park Study models
2006-000215-22Phase 4Completed
- Sponsor
- GSK
- Start
- Feb 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fluticasone propionate in seasonal allergic rhinitis (SAR) (2 arms), sponsored by GSK. Primary endpoint: Weighted mean major symptom complex. Started Feb 2006; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2006-000215-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000215-22.